95 related articles for article (PubMed ID: 9610071)
1. Gene therapy for malignant mesothelioma: a novel approach for an incurable cancer with increased incidence in Louisiana.
Schwarzenberger P; Harrison L; Weinacker A; Gaumer R; Theodossiou C; Summer W; Ye P; Marrogi AJ; Ramesh R; Freeman S; Kolls J
J La State Med Soc; 1998 Apr; 150(4):168-74. PubMed ID: 9610071
[TBL] [Abstract][Full Text] [Related]
2. The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study.
Schwarzenberger P; Harrison L; Weinacker A; Marrogi A; Byrne P; Ramesh R; Theodossiou C; Gaumer R; Summer W; Freeman SM; Kolls JK
Hum Gene Ther; 1998 Nov; 9(17):2641-9. PubMed ID: 9853530
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy.
Sterman DH; Recio A; Vachani A; Sun J; Cheung L; DeLong P; Amin KM; Litzky LA; Wilson JM; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Oct; 11(20):7444-53. PubMed ID: 16243818
[TBL] [Abstract][Full Text] [Related]
6. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
7. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
Su H; Lu R; Ding R; Kan YW
Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy-based treatment strategies for malignant mesothelioma.
Schwarzenberger P; Byrne P; Kolls JK
Curr Opin Mol Ther; 1999 Feb; 1(1):104-11. PubMed ID: 11249674
[TBL] [Abstract][Full Text] [Related]
10. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
11. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
12. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
13. In vivo antitumor effect of herpes simplex virus thymidine kinase gene therapy in rat hepatocellular carcinoma: feasibility of adenovirus-mediated intra-arterial gene delivery.
Kwon HC; Kim JH; Kim KC; Lee KH; Lee JH; Lee BH; Lee KH; Jang JJ; Lee CT; Lee H; Kim CM
Mol Cells; 2001 Apr; 11(2):170-8. PubMed ID: 11355697
[TBL] [Abstract][Full Text] [Related]
14. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
Wildner O; Blaese RM; Candotti F
Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302
[TBL] [Abstract][Full Text] [Related]
15. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
16. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir.
Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV
Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068
[TBL] [Abstract][Full Text] [Related]
17. Technology evaluation: gene therapy (mesothelioma), NCI.
Banerjee D
Curr Opin Mol Ther; 1999 Aug; 1(4):517-20. PubMed ID: 11713768
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
19. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
20. Polyamine depletion and cell cycle manipulation in combination with HSV thymidine kinase/ganciclovir cancer gene therapy.
Wahlfors T; Karppinen A; Jänne J; Alhonen L; Wahlfors J
Int J Oncol; 2006 Jun; 28(6):1515-22. PubMed ID: 16685452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
